Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 0.25% vs 3.02% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 9.22% vs 9.70% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -35.47% vs 5.71% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -33.77% vs -14.79% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of DaShenLin Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -6.20% vs 13.57% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.25% vs 3.02% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 172.75% vs -34.12% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 9.22% vs 9.70% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -14.27% vs -4.37% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -35.47% vs 5.71% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -12.47% vs -12.45% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -33.77% vs -14.79% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






